Litcius/Paper detail

Long-term follow-up of CD19 chimeric antigen receptor T-cell therapy for relapsed/refractory acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation

Yu‐Hong Chen, Xian Zhang, Yifei Cheng, Huan Chen, Xiao‐Dong Mo, Chen‐Hua Yan, Yao Chen, Wei Han, Yuqian Sun, Yu Wang, Xiaohui Zhang, Lan‐Ping Xu, Kai‐Yan Liu, Junfang Yang, Jianping Zhang, Gailing Zhang, Yanze Shi, Yunchao Su, Wenqian Li, Li Xu, Dan Song, Min Zhang, Peihua Lu, Xiao‐Jun Huang

2020Cytotherapy42 citationsDOI

Topics & Concepts

MedicineHematopoietic stem cell transplantationInternal medicineChimeric antigen receptorRefractory (planetary science)TransplantationMinimal residual diseaseGastroenterologyStem cellComplete remissionLeukemiaSurgeryOncologyChemotherapyImmunotherapyCancerBiologyAstrobiologyGeneticsCAR-T cell therapy researchAcute Lymphoblastic Leukemia researchLymphoma Diagnosis and Treatment